Dr Sileida Oliveros

GenesisCare

Dr Sileida Oliveros is a Clinical Oncologist with special interest in Breast cancer. She has over 10 years of clinical experience, obtained a high education degree in Research in Breast Cancer at the Imperial College (London) and currently works in Oxford. She actively participates in Research acting as PI for many Clinical trials, has successfully implemented advanced RT techniques in clinical practice and continues working towards offering each Breast cancer patient state of the art RT. She currently is the Breast cancer lead in Oxford and Thames Valley.

dont miss

Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

We will describe the use of SGRT to optimise patient positioning for radiotherapy for breast cancer, demonstrating improved accuracy and reliability, increased speed of set-up and better patient experience. The contribution of this to enabling advanced radiotherapy practice for breast cancer is discussed.

EVEN MORE SEMINARS

  • Prof Ingunn Holen: Speaking at the Oncology Convention

    Prof Ingunn Holen
    Department of Oncology and Metabolism, University of Sheffield, UK

    Tumour cell dormancy and breast cancer relapse

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Chris Carrigan: Speaking at the Oncology Convention

    Chris Carrigan
    Bowel Cancer Intelligence UK

    Patient Engagement in the uses of Patient Data

  • Dr Abeer Shabaan: Speaking at the Oncology Convention

    Dr Abeer Shabaan
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

  • Dr Shanmugasundaram Ramkumar: Speaking at the Oncology Convention

    Dr Shanmugasundaram Ramkumar
    University Hospital Southampton NHS Foundation Trust

    Radiotherapy developments in management of recurrent rectal cancers